Who
Saira Ramasastry
Director
Company insider
Files Form 4 as: Director, Mirum Pharmaceuticals; Director, Faeth Therapeutics; Director, Day One Biopharmaceuticals; Director, Vir Biotechnology; Director, Akouos; Director, Sangamo Therapeutics; Director, Innovate Biopharmaceuticals; Director, Filana Therapeutics.
In numbers
- Trades disclosed
- 193
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $5.7M
- Companies
- 9
- Companies where not an officer
- 9
- First trade
- 21 Jun 2012
- Last trade
- 15 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $398K3,977 at $100.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $398K3,977 at $100.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $47K2,000 at $23.51 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $219K2,000 at $109.47 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $47K2,000 at $23.51 | filing |
| 15 May 2026filed 18 May 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $219K2,000 at $109.47 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One BiopharmaceuticalsBiotechnology | SEC FORM 4 Code D | —40,485 | filing |
| 23 Apr 2026filed 23 Apr 2026 | Day One Biopharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
News
Mirum Pharmaceuticals to report Livmarli trial results Monday (MIRM:NASDAQ)MIRM · seekingalpha.com · 12 Oct 2026
0 headlines in the last 90 days name Saira Ramasastry; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.